Ensuring the Accessibility, Affordability and Sustainability of Prescription Drugs in Canada

By Society of Actuaries · 2025 · GH201-696-25

Study guide: Exam GH-201C

A reading listed in the SOA’s GH 201C introductory study note as GH201-696-25 (former code GHVR-696-19), titled “Ensuring the Accessibility, Affordability and Sustainability of Prescription Drugs in Canada”. The syllabus assigns it for outcomes 4b of the course, limited to its introduction and executive summary.

On the syllabus

• Exam GH-201C — GH201-696-25: Ensuring the Accessibility, Affordability and Sustainability of Prescription Drugs in Canada (Introduction and Exec Summary only); outcomes 4b.

Contents unavailable The SOA supplies this reading as a study note and no copy of it could be found published online. This page records its citation and assignment from the syllabus and the introductory study note.

Sources

• GH 201C Introductory Study Note, Nov 2026/Mar 2027/Jul 2027 (SOA) — the reading’s code and title in the study-note appendix; former code GHVR-696-19; Authors, Publisher and Year are those of the issuing body and the year in the reading’s code as the syllabus and the study note print them; neither names the document’s author, publisher or date.
• GH 201C Valuation and Regulation, Canada syllabus, Nov 2026/Mar 2027/Jul 2027 (SOA) — the reading as assigned (“GH201-696-25: Ensuring the Accessibility, Affordability and Sustainability of Prescription Drugs in Canada (Introduction and Exec Summary only)”) and the learning outcomes it serves
• CLHIA — Prescription Drugs — a page of the Canadian Life and Health Insurance Association that lists a document with the same title; the document was not read and is not confirmed to be the SOA’s reading